Healthcare Services Group, Inc. (HCSG) fair value analysis

Nasdaq · Updated 2026-09-07

Healthcare Services Group, Inc. is a provider of housekeeping, laundry, and dietary services to senior living communities, hospitals, and other healthcare facilities. The company operates throughout the United States.

Forward Fair Value verdict

Fairly valued

Based on TickrTrends' weekly Forward Fair Value model, HCSG is trading at within about 10% of estimated fair value.

HCSG currently ranks #78 of 113 Healthcare stocks by discount to Forward Fair Value. It has screened as Fairly valued for 3 consecutive weekly runs.

Last price: $23.41
Sector: Healthcare
12-month range: $16.25–$25.11

Derived indicators

Coarse bands from TickrTrends' weekly models; exact figures are part of the full report.

Quality grade: D
Leverage: Low
RSI zone: Neutral
50/200-day trend: Uptrend
52-week position: The top quarter of its range

What our data shows for HCSG

Our model validated 17 trailing price-to-earnings windows for HCSG, built from quarterly earnings records.
Shares are trading in the upper third of their 12-month price range of $16.25–$25.11.
The 14-day relative strength index sits at a neutral 40.

The exact numbers are one step away

The precise Forward Fair Value dollar figure for HCSG
Exact discount / premium to today's price
The normalized historical P/E behind the estimate, and how many quarters support it
Forward EPS input and fiscal-year basis
Screeners and rankings across the full S&P 500 and Nasdaq universes

See the exact fair value →

How Forward Fair Value works

TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.

Recent HCSG news

TickrTrends' derived news-sentiment signal for HCSG is currently mixed, computed from recent coverage.

Strata Critical to Present at the 2026 Jefferies Healthcare Services and Technology Conference (manilatimes.net, 2026-09-08)
Vivos Therapeutics Announces Material Debt Reduction (manilatimes.net, 2026-09-08)
TickrTrends take: Vivos Therapeutics' announcement of material debt reduction represents a potential positive shift in its capital structure that could improve financial flexibility going forward. For a Healthcare sector company currently assessed as fairly valued by TickrTrends, debt reduction may enhance investor confidence by lowering financial risk and improving the ratio of debt to equity. Valuation-focused readers should monitor whether this deleveraging translates into improved cash flow metrics and whether the company can sustain this progress while maintaining its operational investments in the Healthcare market.
RadNet, Inc. to Present at the Jefferies Healthcare Services and Technology Conference on September 15, 2026 (manilatimes.net, 2026-09-08)
TickrTrends take: RadNet's presentation at the Jefferies Healthcare Services and Technology Conference represents an opportunity for investors to gain insight into the company's strategic direction and operational performance within the Healthcare sector. For those monitoring HCSG's valuation context, RadNet's participation in this industry event may signal broader discussions about healthcare service valuations and technology adoption trends that could affect comparable companies. Investors focused on HCSG's fairly valued designation should consider how industry presentations like this one shape market perspectives on growth prospects and competitive positioning within the healthcare services space.

What people are saying

Follow the HCSG conversation: Stocktwits · Reddit · X

TickrTrends weekly updates

2026-09-07 — No material change this week: the verdict, bands and grades all held steady.
2026-09-06 — No material change this week: the verdict, bands and grades all held steady.
2026-08-31 — TickrTrends initiated weekly Forward Fair Value coverage of this stock.

Frequently asked questions

Is HCSG stock undervalued?

Based on TickrTrends' Forward Fair Value model (updated 2026-09-07), HCSG is trading at within about 10% of estimated fair value and screens as fairly valued. The exact fair value and discount are available to subscribers.

What is HCSG's TickrTrends verdict?

HCSG's current verdict is Fairly valued, refreshed with every weekly Forward Fair Value run.

How does HCSG compare to other Healthcare stocks?

HCSG ranks #78 of 113 Healthcare stocks in TickrTrends' coverage when sorted by discount to Forward Fair Value.

Is HCSG overbought or oversold?

HCSG's 14-day RSI is in neutral territory - neither overbought nor oversold.

All Healthcare fair-value coverage →

Head-to-head comparisons

HCSG vs ABBV · HCSG vs ACHC · HCSG vs COR · HCSG vs ELV · HCSG vs JAZZ